Compared with CBZ use, VPA use led to lower levels of IL-2, IL-8, and TNF-α in 120 epilepsy patients, including 60 VPA- and 60 CBZ-treated patients [33], which is similar to our findings. This evidence concerns the gene CXCL8 and epilepsy.